Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
30,719,795
-
Total 13F shares
-
16,339,407
-
Share change
-
+12,769,419
-
Total reported value
-
$31,555,155
-
Price per share
-
$1.93
-
Number of holders
-
48
-
Value change
-
+$26,570,216
-
Number of buys
-
36
-
Number of sells
-
11
Institutional Holders of iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) as of Q4 2025
As of 31 Dec 2025,
iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,339,407 shares.
The largest 10 holders included
EcoR1 Capital, LLC, Affinity Asset Advisors, LLC, Logos Global Management LP, Frazier Life Sciences Management, L.P., Balyasny Asset Management L.P., Ikarian Capital, LLC, VANGUARD GROUP INC, Sio Capital Management, LLC, AMERIPRISE FINANCIAL INC, and TWO SIGMA INVESTMENTS, LP.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.